Piper Sandler
Piper Sandler Initiates Coverage of Cytek Biosciences With Overweight Rating
The investment bank said that Cytek was well positioned to remain one of the fastest growing life science tools companies, thanks to its light-based cell analysis technology.
Progenity Raises $40M in Private Placement
The firm said it will use the funds to support its operations, to invest in its molecular testing research and development program, and for working capital.
Piper Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings
The investment bank said it believes Twist's high growth is "sustainable" and that synthetic biology is the most exciting market in the life sciences sector.
Investment Banks Initiate Coverage of Talis Biomedical With Bullish Outlooks
Talis, which went public last month, develops point-of-care infectious disease tests based on its flagship Talis One sample-to-answer platform.
Progenity Enters $25M Private Placement
The company will issue units representing an aggregate of shares of common stock and warrants to purchase stock shares at an aggregate purchase price of $5.72.